Evaluation of patient management of (radio-)chemotherapy-caused mucositis with the goal of enhancing patient treatment
Journal of Cancer Research and Clinical Oncology · 2025
DOI: 10.1007/s00432-025-06238-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cancer Research and Clinical Oncology, 2025. Verfasst von Helena Wolff und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medical Clinic II, Haematology and Internal Oncology, Jena University Hospital, Friedrich-Schiller-University, Jena, Germany. hlobo246@gmx.de. Hauptthemen laut MEDLINE: Stomatitis, Neoplasms, Chemoradiotherapy, Antineoplastic Agents. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Jena.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Purpose
OM is a very relevant and sometimes therapy-limiting side effect of CT/RCT. There are prophylactic and therapeutic measures available that should be recommended to all patients. This study investigated how patients were informed about oral mucositis (OM) as possible side effect of CT/RCT, how well they knew about available prophylactic and therapeutic measures from the clinical guidelines and to what extent they applied these.
Methods
A standardized questionnaire on information and usage of prophylactic and therapeutic measures and patient-relevant outcomes based on the German S3 Guideline was distributed among patients in German cancer departments.
Results
Only 61.6% of 114 patients were informed about OM as possible side effect by their physician and 53.2% had complaints caused by OM. An insufficient number of patients were recommended to apply prophylactic and therapeutic measures. 63.5% of the patients felt well-informed about treatment options. The most frequently recommended measure was mouth rinse (50%). Only 17.6% of patients were advised to visit a dentist.
Conclusions
The measures proposed in the German S3 guideline were insufficiently recommended. To improve patient education and the quality of care, more intensive use should be made of information flyers, training of nursing staff and greater interdisciplinary cooperation. If treatment-associated OM is to be expected, dental consultations should be firmly integrated into treatment planning.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Clinic II, Haematology and Internal Oncology, Jena University Hospital, Friedrich-Schiller-University, Jena, Germany. hlobo246@gmx.de.
- Haematology and Internal Oncology, MVZ Onkologische Kooperation Harz GbR, Kösliner Straße 14, Goslar, 38642, Germany.
- Medical Clinic II, Haematology and Internal Oncology, Jena University Hospital, Friedrich-Schiller-University, Jena, Germany.
- Medical Clinic II, Haematology and Internal Oncology, Jena University Hospital, Friedrich-Schiller-University, Jena, Germany. Jutta.Huebner@med.uni-jena.de.
Förderung
- Universitätsklinikum Jena
Zitieren
APA
Wolff, H., Zomorodbakhsch, B., Schnizer, M., Keinki, C., & Hübner, J. (2025). Evaluation of patient management of (radio-)chemotherapy-caused mucositis with the goal of enhancing patient treatment. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-025-06238-2
Vancouver
Wolff H, Zomorodbakhsch B, Schnizer M, Keinki C, Hübner J. Evaluation of patient management of (radio-)chemotherapy-caused mucositis with the goal of enhancing patient treatment. Journal of Cancer Research and Clinical Oncology. 2025. doi:10.1007/s00432-025-06238-2
BibTeX
@article{Wolff2025,
author = {Wolff, Helena and Zomorodbakhsch, Bijan and Schnizer, Martin and Keinki, Christian and Hübner, Jutta},
title = {Evaluation of patient management of (radio-)chemotherapy-caused mucositis with the goal of enhancing patient treatment},
journal = {Journal of Cancer Research and Clinical Oncology},
year = {2025},
doi = {10.1007/s00432-025-06238-2}
}
EUVIMED